Evidence map›Paper›PMID 28187438›Full record

ReviewOncotarget2017

Tat is a multifunctional viral protein that modulates cellular gene expression and functions.

Evan Clark, Brenda Nava, Massimo Caputi

Abstract readReview
In one paragraph

Review in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Recombinant Cell-Permeable PuromycinJournal of microbiology and biotechnology · 2025
    Article
  19. Article
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Evan ClarkCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA.
Brenda NavaCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA.
Massimo CaputiCharles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA.

Funding

Inhibition of HIV-1 replication by delivery of the SRSF1 RNA Recognition MotifsR15AI120882 · NIAID · FLORIDA ATLANTIC UNIVERSITY · PI CAPUTI, MASSIMO · 2015 to 2015
$449k
NIAID NIH HHS R15 AI120882
6 · The paper itself

Abstract

The human immunodeficiency virus type I (HIV-1) has developed several strategies to condition the host environment to promote viral replication and spread. Viral proteins have evolved to perform multiple functions, aiding in the replication of the viral genome and modulating the cellular response to the infection. Tat is a small, versatile, viral protein that controls transcription of the HIV genome, regulates cellular gene expression and generates a permissive environment for viral replication by altering the immune response and facilitating viral spread to multiple tissues. Studies carried out utilizing biochemical, cellular, and genomic approaches show that the expression and activity of hundreds of genes and multiple molecular networks are modulated by Tat via multiple mechanisms.

Indexed as

Gene Expression RegulationAnimalsApoptosisDisease SusceptibilityGene Expression Regulation, ViralHIV-1HIV InfectionsHost-Pathogen InteractionsHumansImmunomodulationMicroRNAsProtein Transporttat Gene Products, Human Immunodeficiency VirusTranscriptional ActivationMicroRNAstat Gene Products, Human Immunodeficiency Virusgene regulationHIV-1Tattranscription

Identifiers

PMID28187438
PMCPMC5432358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.